Hemodynamic Monitoring Devices Market Worth $1.4 Billion By 2024
The global Hemodynamic Monitoring Devices Market is expected to reach USD 1.4 billion by 2024, according to a new report by Grand View Research, Inc. The increasing demand for noninvasive monitoring techniques coupled with the rising prevalence of chronic illness is expected to drive the market over the forecast period. The hemodynamic monitoring market is influenced by new technologies such as echocardiography, thoracic electrical bio-impedance and others that maybe used to noninvasively monitor parameters such as cardiac output, arterial pressure, blood oxygen level, and central venous pressure. Furthermore, the rising population of critically ill patients coupled with defective healthcare facilities with drawbacks, such as understaffing, is propelling market players to develop minimal invasive hemodynamic monitoring devices that may be used in clinical and home care settings. Along with the new product development, the market is also anticipated to witness the development of technologies that help in the early diagnosis of shock and sepsis. Furthermore, efforts by key industry players to understand critical illnesses at molecular levels leading to the development of efficient assessment products are expected to be witnessed over the forecast period. Hence, all these company strategies and the research conducted are eventually expected to promote market growth over the forecast period.
View summary of this report @ http://www.grandviewresearch.com/industryanalysis/hemodynamic-monitoring-devices-market North America Hemodynamic Monitoring Devices Market share, by product, 2014-2024 (USD Million)
Table of Content Chapter 1. Methodology And Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions 1.3. List of Data Sources Chapter 2. Executive Summary 2.1. Hemodynamic Monitoring - Industry Snapshot and Key Buying Criteria, 2013 - 2024 Chapter 3. Hemodynamic Monitoring Industry Outlook 3.1. Market segmentation 3.2. Market size and growth prospects 3.3. Hemodynamic Monitoring: Market dynamics 3.3.1. Market driver analysis 3.3.2. Market restraint analysis 3.4. Key opportunities prioritized 3.5. Industry Analysis - Porter's 3.6. Hemodynamic Monitoring market PESTEL analysis, 2015 3.7. Company market share, 2015 Chapter 4. Hemodynamic Monitoring Product Outlook 4.1. Hemodynamic monitoring market share by product, 2015 & 2024
4.2. Hemodynamic monitoring systems 4.2.1. Hemodynamic monitoring systems market estimates, 2013 - 2015 (USD Million) 4.2.2. Hemodynamic monitoring systems market forecasts, 2016 - 2024 (USD Million) 4.2.3. Pulmonary artery catheters 4.2.3.1. Pulmonary artery catheters market estimates,2013 - 2015 (USD Million) 4.2.3.2. Pulmonary artery catheters market forecasts, 2016 - 2024 (USD Million) 4.2.4. Cardiac output monitoring system 4.2.4.1. Cardiac output monitoring system market estimates,2013 - 2015 (USD Million) 4.2.4.2. Cardiac output monitoring system market forecasts, 2016 - 2024 (USD Million) 4.2.5. Others 4.2.5.1. Other monitoring system market estimates, 2013 - 2015 (USD Million) 4.2.5.2. Other monitoring system market forecasts, 2016 - 2024 (USD Million) 4.3. Disposables 4.3.1. Disposables market estimates, 2013 - 2015 (USD Million) 4.3.2. Disposables market forecasts, 2016 - 2024 (USD Million) 4.3.3. Probes 4.3.3.1. Probes market estimates, 2013 - 2015 (USD Million) 4.3.3.2. Probes market forecasts, 2016 - 2024 (USD Million) 4.3.4. Airflow sensors 4.3.4.1. Airflow sensors market estimates, 2013 - 2015 (USD Million) 4.3.4.2. Airflow sensors market forecasts, 2016 - 2024 (USD Million) 4.3.5. Circuits 4.3.5.1. Circuits market estimates, 2013 - 2015 (USD Million) 4.3.5.2. Circuits market forecasts, 2016 - 2024 (USD Million) 4.3.6. Other disposables 4.3.6.1. Other disposable market estimates, 2013 - 2015 (USD Million) 4.3.6.2. Other disposable market forecasts, 2016 - 2024 (USD Million) 4.4. Services 4.4.1. Services market estimates, 2013 - 2015 (USD Million) 4.4.2. Services market forecasts, 2016 - 2024 (USD Million) Chapter 5. Hemodynamic Monitoring Type Outlook
5.1. Hemodynamic Monitoring market share by type, 2015 & 2024 5.2. Invasive hemodynamic monitoring system 5.2.1. Invasive hemodynamic monitoring system market estimates, 2013 - 2015 (USD Million) 5.2.2. Invasive hemodynamic monitoring system market forecasts, 2016 - 2024 (USD Million) 5.3. Minimally invasive hemodynamic monitoring system 5.3.1. Minimally invasive hemodynamic monitoring system market estimates, 2013 - 2015 (USD Million) 5.3.2. Minimally invasive hemodynamic monitoring system market forecasts, 2016 - 2024 (USD Million) 5.4. Non-invasive hemodynamic monitoring system 5.4.1. Non-invasive hemodynamic monitoring system market estimates, 2013 2015 (USD Million) 5.4.2. Non-invasive hemodynamic monitoring system market forecasts, 2016 2024 (USD Million) Chapter 6. Hemodynamic Monitoring End-use Outlook 6.1. Hemodynamic Monitoring market share by end-use, 2015 & 2024 6.2. Hospitals 6.2.1. Hospital based hemodynamic monitoring market estimates, 2013 - 2015 (USD Million) 6.2.2. Hospital based hemodynamic monitoring market forecasts, 2016 - 2024 (USD Million) 6.3. Catheterization laboratory 6.3.1. Catheterization laboratory based hemodynamic monitoring market estimates and forecasts, 2013 - 2024 (USD Million) 6.4. Other 6.4.1. Other end-use based hemodynamic monitoring market estimates and forecasts, 2013 - 2024 (USD Million) Chapter 7. Hemodynamic Monitoring Regional Outlook 7.1. Hemodynamic Monitoring market share, by region, 2015 & 2024 7.2. North America 7.2.1. Market estimates and forecasts, by product, 2013 - 2024 (USD Million) 7.2.2. Market estimates and forecasts, by type, 2013 - 2024 (USD Million) 7.2.3. Market estimates and forecasts, by end-use, 2013 - 2024 (USD Million) 7.2.3.1. U.S. 7.2.3.2. Canada 7.3. Europe 7.3.1. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
7.3.2. Market estimates and forecasts, by type, 2013 - 2024 (USD Million) 7.3.3. Market estimates and forecasts, by end-use, 2013 - 2024 (USD Million) 7.3.3.1. UK 7.3.3.2. Germany 7.4. Asia Pacific 7.4.1. Market estimates and forecasts, by product, 2013 - 2024 (USD Million) 7.4.2. Market estimates and forecasts, by type, 2013 - 2024 (USD Million) 7.4.3. Market estimates and forecasts, by end-use, 2013 - 2024 (USD Million) 7.4.3.1. Japan 7.4.3.2. China 7.5. Latin America 7.5.1. Market estimates and forecasts, by product, 2013 - 2024 (USD Million) 7.5.2. Market estimates and forecasts, by type, 2013 - 2024 (USD Million) 7.5.3. Market estimates and forecasts, by end-use, 2013 - 2024 (USD Million) 7.5.3.1. Brazil 7.5.3.2. Mexico 7.6. MEA 7.6.1. Market estimates and forecasts, by product, 2013 - 2024 (USD Million) 7.6.2. Market estimates and forecasts, by type, 2013 - 2024 (USD Million) 7.6.3. Market estimates and forecasts, by end-use, 2013 - 2024 (USD Million) 7.6.3.1. South Africa 7.6.3.2. Saudi Arabia Chapter 8. Competitive Landscape 8.1. LiDCO Group Plc 8.1.1. Company Overview 8.1.2. Financial Performance 8.1.3. Product Benchmarking 8.1.4. Strategic Initiatives 8.2. Philips Medical Systems 8.2.1. Company Overview 8.2.2. Financial Performance 8.2.3. Product Benchmarking 8.2.4. Strategic Initiatives 8.3. Drager Medical Inc. 8.3.1. Company Overview 8.3.2. Financial Performance 8.3.3. Product Benchmarking 8.3.4. Strategic Initiatives 8.4. Deltex Medical Group Plc
8.4.1. Company Overview 8.4.2. Financial Performance 8.4.3. Product Benchmarking 8.4.4. Strategic Initiatives 8.5. Tensys Medical Inc. 8.5.1. Company Overview 8.5.2. Financial Performance 8.5.3. Product Benchmarking 8.5.4. Strategic Initiatives 8.6. Noninvasive Medical Technologies Inc. 8.6.1. Company Overview 8.6.2. Financial Performance 8.6.3. Product Benchmarking 8.6.4. Strategic Initiatives 8.7. GE Healthcare 8.7.1. Company Overview 8.7.2. Financial Performance 8.7.3. Product Benchmarking 8.7.4. Strategic Initiatives 8.8. Edward Lifesciences 8.8.1. Company Overview 8.8.2. Financial Performance 8.8.3. Product Benchmarking 8.8.4. Strategic Initiatives 8.9. CAS Medical Systems 8.9.1. Company Overview 8.9.2. Financial Performance 8.9.3. Product Benchmarking 8.9.4. Strategic Initiatives 8.10. Cardio-Dynamics International 8.10.1. Company Overview 8.10.2. Financial Performance 8.10.3. Product Benchmarking 8.10.4. Strategic Initiatives
Browse full report @ http://www.grandviewresearch.com/industry-analysis/hemodynamicmonitoring-devices-market
List of Tables TABLE 1 Country share estimation TABLE 2 Hemodynamic Monitoring Device- Industry Snapshot & Key Buying Criteria, 20132024 TABLE 3 Global Hemodynamic Monitoring Devicemarket, by product, 2013 - 2024 (USD Million) TABLE 4 Global Hemodynamic Monitoring Devicemarket, by type,2013 - 2024 (USD Million) TABLE 5 Global Hemodynamic Monitoring Devicemarket, by region, 2013 - 2024 (USD Million) TABLE 6 Hemodynamic Monitoring Device- Key market driver analysis TABLE 7 Hemodynamic Monitoring Device- Key market restraint analysis TABLE 8 North America Hemodynamic Monitoring Devicemarket, by region, 2013 - 2024 (USD Million) TABLE 9 North America Hemodynamic Monitoring Devicemarket, by product, 2013 - 2024 (USD Million) TABLE 10 North AmericaHemodynamic Monitoring Devicemarket, by type, 2013 - 2024 (USD Million) TABLE 11 U.S. Hemodynamic Monitoring Devicemarket, by product, 2013 - 2024 (USD Million) TABLE 12 U.S. Hemodynamic Monitoring Devicemarket, by type, 2013 - 2024 (USD Million) TABLE 13 Canada Hemodynamic Monitoring Devicemarket, by product, 2013 - 2024 (USD Million) TABLE 14 Canada Hemodynamic Monitoring Devicemarket, by type, 2013 - 2024 (USD Million) TABLE 15 Europe Hemodynamic Monitoring Devicemarket, by region, 2013 - 2024 (USD Million) TABLE 16 Europe Hemodynamic Monitoring Devicemarket, by product, 2013 - 2024 (USD Million) TABLE 17 Europe Hemodynamic Monitoring Devicemarket, by type, 2013 - 2024 (USD Million) TABLE 18 UK Hemodynamic Monitoring Devicemarket, by product, 2013 - 2024 (USD Million) TABLE 19 UK Hemodynamic Monitoring Devicemarket, by type, 2013 - 2024 (USD Million) TABLE 20 Germany Hemodynamic Monitoring Devicemarket, by product, 2013 - 2024 (USD Million) TABLE 21 Germany Hemodynamic Monitoring Devicemarket, by type,2013 - 2024 (USD Million) TABLE 22 Asia Pacific Hemodynamic Monitoring Devicemarket, by region, 2013 - 2024 (USD Million) TABLE 23 Asia Pacific Hemodynamic Monitoring Devicemarket, by product, 2013 - 2024 (USD Million) TABLE 24 Asia Pacific Hemodynamic Monitoring Devicemarket, by type,2013 - 2024 (USD Million) TABLE 25 Japan Hemodynamic Monitoring Devicemarket, by product, 2013 - 2024 (USD
Million) TABLE 26 Japan Hemodynamic Monitoring Devicemarket, by type,2013 - 2024 (USD Million) TABLE 27 China Hemodynamic Monitoring Devicemarket, by product, 2013 - 2024 (USD Million) TABLE 28 China Hemodynamic Monitoring Devicemarket, by type, 2013 - 2024 (USD Million) TABLE 29 Latin America Hemodynamic Monitoring Devicemarket, by region, 2013 - 2024 (USD Million) TABLE 30 Latin America Hemodynamic Monitoring Devicemarket, by product, 2013 - 2024 (USD Million) TABLE 31 Latin America Hemodynamic Monitoring Devicemarket, by type, 2013 - 2024 (USD Million) TABLE 32 Brazil Hemodynamic Monitoring Devicemarket, by product, 2013 - 2024 (USD Million) TABLE 33 Brazil Hemodynamic Monitoring Devicemarket, by type, 2013 - 2024 (USD Million) TABLE 34 Argentina Hemodynamic Monitoring Devicemarket, by product, 2013 - 2024 (USD Million) TABLE 35 Argentina Hemodynamic Monitoring Devicemarket, by type,2013 - 2024 (USD Million) TABLE 36 MEA Hemodynamic Monitoring Devicemarket, by region, 2013 - 2024 (USD Million) TABLE 37 MEA Hemodynamic Monitoring Devicemarket, by product, 2013 - 2024 (USD Million) TABLE 38 MEA Hemodynamic Monitoring Devicemarket, by type, 2013 - 2024 (USD Million) TABLE 39 South Africa Hemodynamic Monitoring Devicemarket, by product, 2013 - 2024 (USD Million) TABLE 40 South Africa Hemodynamic Monitoring Devicemarket, by type, 2013 - 2024 (USD Million) TABLE 41 Saudi Arabia Hemodynamic Monitoring Devicemarket, by product, 2013 - 2024 (USD Million) TABLE 42 Saudi Arabia Hemodynamic Monitoring Devicemarket, by type,2013 - 2024 (USD Million)
For More Information visit http://www.grandviewresearch.com/industryanalysis/hemodynamic-monitoring-devices-market
List of Figures FIG. 1 Market summary FIG. 2 Hemodynamic Monitoring Device: Market Segmentation FIG. 3 Hemodynamic Monitoring Devices Market revenue, 2013 - 2024 (USD Million) FIG. 4 Hemodynamic Monitoring Device: Market Dynamics
FIG. 8 Global geriatric population, 2013 - 2024 (Million) FIG. 9 Global geriatric population, 2013 - 2024 (Million) FIG. 10 Percentage of geriatric population in European countries, 2015 FIG. 11 Percentage of geriatric population in European countries, 2015 FIG. 13 Key Opportunities Prioritized FIG. 14 Hemodynamic Monitoring Device Porter’s analysis FIG. 15 Therapeutic bed- PESTEL analysis FIG. 16 Global Hemodynamic Monitoring Devices Market share, by product, 2015 & 2024 FIG. 17 Clinical beds market, 2013 - 2024 (USD Million) FIG. 18 Regular beds market, 2013 - 2024 (USD Million) FIG. 19 ICU beds market, 2013 - 2024 (USD Million) FIG. 20 ICU beds market, 2013 - 2024 (USD Million) FIG. 21 Birthing beds market, 2013 - 2024 (USD Million) FIG. 22 Bariatric beds market, 2013 - 2024 (USD Million) FIG. 23 Low air loss beds market, 2013 - 2024 (USD Million) FIG. 24 Other beds market, 2013 - 2024 (USD Million) FIG. 25 Household beds market, 2013 - 2024 (USD Million) FIG. 26 Accessories market, 2013 - 2024 (USD Million) FIG. 27 Global Hemodynamic Monitoring Devices Market share, by type, 2015 & 2024 FIG. 28 Acute care beds market, 2013 - 2024 (USD Million) FIG. 29 Critical care beds market, 2013 - 2024 (USD Million) FIG. 30 Long-term beds market, 2013 - 2024 (USD Million) FIG. 31 Hemodynamic Monitoring Devices Market share, by region, 2015 & 2024 FIG. 32 North America Hemodynamic Monitoring Devices Market, 2013 - 2024 (USD Million) FIG. 33 U.S.Hemodynamic Monitoring Devices Market,2013 - 2024 (USD Million) FIG. 34 CanadaHemodynamic Monitoring Devices Market, 2013 - 2024 (USD Million) FIG. 35 EuropeHemodynamic Monitoring Devices Market, 2013 - 2024 (USD Million) FIG. 36 GermanyHemodynamic Monitoring Devices Market, 2013 - 2024 (USD Million) FIG. 37 UKHemodynamic Monitoring Devices Market,2013 - 2024 (USD Million) FIG. 38 Asia PacificHemodynamic Monitoring Devices Market, 2013 - 2024 (USD Million) FIG. 39 Japan Hemodynamic Monitoring Devices Market, 2013 - 2024 (USD Million) FIG. 40 ChinaHemodynamic Monitoring Devices Market,2013 - 2024 (USD Million) FIG. 41 Latin AmericaHemodynamic Monitoring Devices Market,2013 - 2024 (USD Million) FIG. 42 Brazil Hemodynamic Monitoring Devices Market,2013 - 2024 (USD Million) FIG. 43 Argentina Hemodynamic Monitoring Devices Market,2013 - 2024 (USD Million) FIG. 44 Middle East and Africa Hemodynamic Monitoring Devices Market,2013 - 2024 (USD Million) FIG. 45 South Africa Hemodynamic Monitoring Devices Market, 2013 - 2024 (USD Million) FIG. 46 Saudi Arabia Hemodynamic Monitoring Devices Market, 2013 - 2024 (USD Million)
Further key findings from the study suggest:
The disposables segment is anticipated to be the largest segment by 2024. The rising sale of hemodynamic monitoring systems and increasing applications of these systems in home care settings, hospitals, and clinics are expected to boost the segment growth. The non-invasive devices segment is expected to be the fastest growing hemodynamic monitoring market. Risks that include the development of arrhythmias due to the use of pulmonary artery catheter and the development of other methodologies that measure the cardiac output, such as echocardiographs, are the vital impact rendering drivers. Asia Pacific is anticipated to be the fastest growing regions and is anticipated to contribute to about 20.0% of the global revenue by 2024. The strengthening of the distribution channels by companies and the registration of products in countries, such as China, India, Australia, and others, are expected to support the growth over the forecast period. For instance, LiDCO Group, in their 2016 prelim report emphasized on its strategy of appointing new distributors for the Australian and South East Asian region. Major industry players are Edward Lifesciences, LiDCO Group Plc, Deltex Medical, Philips Medical, GE Healthcare, Noninvasive Medical Technologies, Inc., Tensys Medical, Inc., Cardio-Dynamics International, and Drager Medical, Inc. As mentioned above, the new product development is expected to drive the market over the forecast period. For instance, in March 2016, the LiDCO Group received the U.S. FDA approval for the LiDCO unity and launched the product in the European region. Along the same time, LiDCO also succeeded in registering itself in China to explore untapped territories and increase their global presence.
Request free sample of this Report @ http://www.grandviewresearch.com/industryanalysis/hemodynamic-monitoring-devices-market/request
Grand View Research has segmented the Hemodynamic Monitoring Devices Market on the basis of product, type, end-use and regions. Global Hemodynamic Monitoring Devices Product Outlook (Revenue, USD Million, 2014 – 2024)
Monitoring systems Pulmonary artery catheters Cardiac output monitors Others Disposables Probes Airflow Sensors
Circuits Others Services
Global Hemodynamic Monitoring Devices Type Outlook (Revenue, USD Million, 2014 – 2024)
Invasive Hemodynamic Monitoring System Minimally Invasive Hemodynamic Monitoring System Non-invasive Hemodynamic Monitoring System
Global Hemodynamic Monitoring Devices End-use Outlook (Revenue, USD Million, 2014 – 2024)
Hospitals Catheterization Laboratories Others
Hemodynamic Monitoring Devices Market Regional Outlook (Revenue, USD Million, 2014 – 2024)
North America U.S. Canada Europe UK Germany Asia Pacific Japan China Latin America Brazil Mexico MEA South Africa Saudi Arabia
Browse
All
Reports
of
this
http://www.grandviewresearch.com/industry/medical-devices
category
@
About Grand View Research Grand View Research, Inc. is a market research and consulting company that provides off-theshelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deepseated understanding of varied business environments, Grand View Research provides strategic objective insights.
Contact: Sherry James Corporate Sales Specialist, U.S.A. Grand View Research, Inc. United States Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: sales@grandviewresearch.com Website: Grand View Research Blog Site: http://www.divog.org/